Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kearney

Showing results (241-250 of 296) with videos related to

Pageof 30
Sort By:
Applied Optics|October 19, 2023
Nitrogen thermometry in an inductively coupled plasma torch using broadband nanosecond coherent anti-Stokes Raman scatteringDan Fries, Spenser T Stark, John S Murray, et al.
Arthritis and Rheumatism|March 20, 1998
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantationJ A Snowden, P Kearney, A Kearney, et al.
The Journal of Infectious Diseases|February 12, 2010
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trialAndrew R Zolopa, Daniel S Berger, Harry Lampiris, et al.
Optics Letters|November 2, 2018
Single-camera, single-shot, time-resolved laser-induced incandescence decay imagingYi Chen, Emre Cenker, Daniel R Richardson, et al.
Ultrasound in Medicine & Biology|January 1, 1997
Characterisation of atherosclerotic plaque by spectral analysis of intravascular ultrasound: an in vitro methodologyT Spencer, M P Ramo, D M Salter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 18, 2016
Pharmacokinetics of Co-Formulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate After Switch From Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Healthy SubjectsSrini Ramanathan, Joseph M Custodio, Xuelian Wei, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy SubjectsErik Mogalian, Polina German, Brian P Kearney, et al.
Journal of Cellular Biochemistry|August 1, 1994
Space shuttle flight (STS-45) of L8 myoblast cells results in the isolation of a nonfusing cell line variantD A Kulesh, L H Anderson, B Wilson, et al.
British Journal of Clinical Pharmacology|December 14, 2011
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settingsMamoon A Aldeyab, Stephan Harbarth, Nathalie Vernaz, et al.
Nano Letters|January 5, 2012
Manipulating thermal conductance at metal-graphene contacts via chemical functionalizationPatrick E Hopkins, Mira Baraket, Edward V Barnat, et al.
Pageof 30

Showing results (241-250 of 296) with videos related to

Sort By:
Pageof 30
Applied Optics|October 19, 2023
Nitrogen thermometry in an inductively coupled plasma torch using broadband nanosecond coherent anti-Stokes Raman scatteringDan Fries, Spenser T Stark, John S Murray, et al.
Arthritis and Rheumatism|March 20, 1998
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantationJ A Snowden, P Kearney, A Kearney, et al.
The Journal of Infectious Diseases|February 12, 2010
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trialAndrew R Zolopa, Daniel S Berger, Harry Lampiris, et al.
Optics Letters|November 2, 2018
Single-camera, single-shot, time-resolved laser-induced incandescence decay imagingYi Chen, Emre Cenker, Daniel R Richardson, et al.
Ultrasound in Medicine & Biology|January 1, 1997
Characterisation of atherosclerotic plaque by spectral analysis of intravascular ultrasound: an in vitro methodologyT Spencer, M P Ramo, D M Salter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 18, 2016
Pharmacokinetics of Co-Formulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate After Switch From Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Healthy SubjectsSrini Ramanathan, Joseph M Custodio, Xuelian Wei, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy SubjectsErik Mogalian, Polina German, Brian P Kearney, et al.
Journal of Cellular Biochemistry|August 1, 1994
Space shuttle flight (STS-45) of L8 myoblast cells results in the isolation of a nonfusing cell line variantD A Kulesh, L H Anderson, B Wilson, et al.
British Journal of Clinical Pharmacology|December 14, 2011
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settingsMamoon A Aldeyab, Stephan Harbarth, Nathalie Vernaz, et al.
Nano Letters|January 5, 2012
Manipulating thermal conductance at metal-graphene contacts via chemical functionalizationPatrick E Hopkins, Mira Baraket, Edward V Barnat, et al.
Pageof 30